Article metrics

Download PDFPDF

529 Phase 1 study of INCB086550, an oral PD-L1 inhibitor, in immune-checkpoint naive patients with advanced solid tumors
Free

 

Online download statistics by month:

Online download statistics by month: November 2021 to January 2024

AbstractFullPdf
Nov 202113890842
Dec 2021324060
Jan 2022215055
Feb 2022132028
Mar 2022380055
Apr 2022214045
May 2022194050
Jun 2022144064
Jul 202272020
Aug 2022104035
Sep 202298040
Oct 2022112039
Nov 2022122037
Dec 2022162023
Jan 202386021
Feb 2023134016
Mar 2023112017
Apr 2023112020
May 202396016
Jun 2023122016
Jul 202398029
Aug 2023118019
Sep 2023106018
Oct 2023102022
Nov 2023120015
Dec 2023138016
Jan 2024198010
Total520401628